Radboud University Medical Center
🇳🇱Netherlands
- Country
- 🇳🇱Netherlands
- Ownership
- Private
- Established
- 1951-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.radboudumc.nl
Immunomodulatory Effects of Dexamethasone, Tocilizumab and Anakinra During Experimental Human Endotoxemia
Phase 4
Not yet recruiting
- Conditions
- SepsisNeuroinflammatory ResponseImmunosuppresionEndotoxemiaAnakinraDexamethasoneTocilizumab
- Interventions
- First Posted Date
- 2024-10-03
- Last Posted Date
- 2024-10-03
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 52
- Registration Number
- NCT06624436
- Locations
- 🇳🇱
Intensive Care Medicine, Radboud University Nijmegen Medical Centre, Nijmegen, Gelderland, Netherlands
Feasibility of Nurse-performed Gastric Ultrasound After Surgery
Recruiting
- Conditions
- Point-of-care-ultrasoundGastric UltrasonographyGastric UltrasoundGastro Intestinal SurgeryNursingAbdominal Surgeries
- Interventions
- Diagnostic Test: gastric ultrasonograppy
- First Posted Date
- 2024-10-01
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 135
- Registration Number
- NCT06620549
- Locations
- 🇳🇱
RadboudUMC, Nijmegen, Gelderland, Netherlands
🇳🇱Radboudumc, Nijmegen, Netherlands
Distraction As Multimodal Pain Management
Not Applicable
Not yet recruiting
- Conditions
- Pain, AcuteBurnsPediatric ALL
- Interventions
- Device: Distraction by use of kaleidoscope
- First Posted Date
- 2024-09-11
- Last Posted Date
- 2024-09-11
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 126
- Registration Number
- NCT06591195
Enhancement of Quality of Work And Life
Not Applicable
Not yet recruiting
- Conditions
- AtaxiaParkinsonismParkinson DiseaseHereditary Spastic Paraparesis
- Interventions
- Behavioral: Participatory workplace intervention
- First Posted Date
- 2024-08-27
- Last Posted Date
- 2024-08-27
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 124
- Registration Number
- NCT06573866
The ROAD 2.0 to Sustainable Medication Use: Redispensing Unused Oral Anticancer Drugs
Not Applicable
Recruiting
- Conditions
- PharmacyOncologyCancerDrug Prescriptions
- Interventions
- Other: redispensing oral anticancer drugs
- First Posted Date
- 2024-08-22
- Last Posted Date
- 2024-08-22
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 2500
- Registration Number
- NCT06566560
- Locations
- 🇳🇱
Radboudumc, Nijmegen, Gelderland, Netherlands
Sensitivity of Self-collected Skin Sampling for Scabies: a Pilot Study
Early Phase 1
Recruiting
- Conditions
- Scabies
- Interventions
- Diagnostic Test: Skin sampling
- First Posted Date
- 2024-08-09
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 144
- Registration Number
- NCT06546579
- Locations
- 🇳🇱
Radboudumc, Nijmegen, Gelderland, Netherlands
Real-life Clinical Experience With Ialuadapter Study
Completed
- Conditions
- Recurrent Urinary Tract InfectionInterstitial Cystitis, ChronicOveractive Bladder Syndrome
- Interventions
- Device: Ialuadapter
- First Posted Date
- 2024-08-06
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 61
- Registration Number
- NCT06540248
- Locations
- 🇳🇱
Radboudumc, Nijmegen, Gelderland, Netherlands
TreatmENT of AnastomotiC LeakagE After COLON Cancer Resection
Not yet recruiting
- Conditions
- Anastomotic LeakageColon CancerResectionTreatment
- First Posted Date
- 2024-07-30
- Last Posted Date
- 2024-07-30
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 2000
- Registration Number
- NCT06528054
South East (Zuid Oost) Netherlands Heart Registry
Recruiting
- Conditions
- Coronary Artery DiseaseAcute Coronary SyndromeChronic Coronary Syndrome
- First Posted Date
- 2024-07-22
- Last Posted Date
- 2024-07-25
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 99999
- Registration Number
- NCT06512493
- Locations
- 🇳🇱
MaastrichtUMC+, Maastricht, Limburg, Netherlands
🇳🇱VieCuri, Venlo, Limburg, Netherlands
🇳🇱Radboud University Medical Centre, Nijmegen, Netherlands
Methylphenidate in KBG Syndrome: N-of-1 Series
Phase 4
Recruiting
- Conditions
- Kbg SyndromeADHD - Combined Type
- Interventions
- Drug: PlaceboDrug: Methylphenidate Hydrochloride
- First Posted Date
- 2024-06-20
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 15
- Registration Number
- NCT06465641
- Locations
- 🇳🇱
Radboud University Medical Center, Nijmegen, Gelderland, Netherlands
© Copyright 2025. All Rights Reserved by MedPath